» Articles » PMID: 38625334

The Relationship Between Grip Strength with Health-related Quality of Life and Mortality in Hemodialysis Patients

Overview
Journal Nutrire
Date 2024 Apr 16
PMID 38625334
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Hemodialysis (HD) is a therapeutic modality that enables the highest survival for individuals with chronic kidney disease (CKD). In contrast, HD contributes to the pro-inflammatory state and may negatively affect the muscle strength and quality of life (QoL) of these individuals. To date, few studies have evaluated the association between decrease in strength and QoL in HD patients. Thus, our objective was to assess whether diminished muscle strength is associated with worse health related QoL and mortality.

Methods: We included patients aged ≥ 18 years on HD. Clinical and demographic data were collected from patients' medical records. Clinical data, nutritional status (laboratory, anthropometry, bioimpedance analysis) and health-related QoL (World Health Organization's quality of life questionnaire, WHOQOL-Bref) were analyzed at baseline. Mortality was recorded for 32 months.

Results: Among the 105 patients evaluated, the median age was 52 (43-64) years, and males were predominant (n = 73; 70%). The general median of QoL was 66.8 ± 11.9. Approximately 30% of patients were considered to have a worse QoL and 12,4% to have low muscle strength. This was not associated with QoL and mortality. HD vintage greater then to 5 years was associated with higher dissatisfaction in the perception of the environmental domain and overall QoL.

Conclusion: Our data suggest that low muscle strength was not associated with health-related QoL using the WHOQOL-Bref instrument and mortality.

Citing Articles

Views, attitudes, and reported practices of nephrology nurses regarding shared decision-making in end-of-life care.

Hatoum W, Sperling D Nurs Ethics. 2023; 31(5):739-758.

PMID: 37794561 PMC: 11370162. DOI: 10.1177/09697330231200565.

References
1.
Donini L, Busetto L, Bischoff S, Cederholm T, Ballesteros-Pomar M, Batsis J . Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022; 15(3):321-335. PMC: 9210010. DOI: 10.1159/000521241. View

2.
Saran R, Robinson B, Abbott K, Agodoa L, Albertus P, Ayanian J . US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017; 69(3 Suppl 1):A7-A8. PMC: 6605045. DOI: 10.1053/j.ajkd.2016.12.004. View

3.
Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani C . Sarcopenia in chronic kidney disease: what have we learned so far?. J Nephrol. 2020; 34(4):1347-1372. PMC: 8357704. DOI: 10.1007/s40620-020-00840-y. View

4.
Kang S, Kim A, Kim J, Do J . Comparison of Body Composition, Strength, and Physical Performance Measurements Between Healthy Participants and Hemodialysis Patients. Int J Gen Med. 2021; 14:7173-7179. PMC: 8558505. DOI: 10.2147/IJGM.S336082. View

5.
Sukackiene D, Laucyte-Cibulskiene A, Vickiene A, Rimsevicius L, Miglinas M . Risk stratification for patients awaiting kidney transplantation: Role of bioimpedance derived edema index and nutrition status. Clin Nutr. 2019; 39(9):2759-2763. DOI: 10.1016/j.clnu.2019.12.001. View